Webinar: Upcoming- Building a Better Cell Therapy Potency Assay Through Multianalyte Profiling
Webinar Summary
Register to tune-in live
Potency testing is a critical component of cell therapy development, yet many current assays rely on a single biomarker, such as IFN-γ, that may not fully capture immune cell function. As CAR-T and CAR-NK therapies become more sophisticated, there is a growing need for potency assays that provide a more comprehensive and biologically relevant assessment of therapeutic activity.
This webinar presents a data-driven strategy for developing multianalyte potency assays that pairs broad biomarker discovery with sensitive, automated protein quantification. Using CD19 CAR-T and CAR-NK cells from multiple donors, this webinar will show how multiplex profiling identifies the most informative biomarkers and translates them into targeted potency assays that more faithfully reflect effector cell function and advance assay standardization
Whether you're developing new potency assays, optimizing existing workflows, or exploring alternative approaches beyond single-analyte testing, this session provides practical guidance for building more informative potency assays for cell therapies.
What You'll Learn:
- Why measuring multiple biomarkers provides a more comprehensive assessment of CAR-T and CAR-NK cell potency than traditional single-analyte assays
- How multiplex protein profiling can be used to identify and prioritize biomarkers that best represent immune cell function
- A practical workflow for transitioning from broad biomarker discovery to standardized, automated multianalyte potency assays for reproducible potency testing
Who Should Attend:
This webinar is ideal for scientists involved in:
- Cell therapy analytical & process development
- Potency assay development
- Cell therapy quality control (QC) and characterization, & manufacturing sciences